Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Insmed, Inc. (INSM) vs BeOne Medicines Ltd. - Sponsored ADR (ONC)

Insmed, Inc. and BeOne Medicines Ltd. - Sponsored ADR are both Biotechnology companies. BeOne Medicines Ltd. - Sponsored ADR is the larger, with a market value of $37.3B against $26.8B — 1.4× the size. Insmed, Inc. has negative trailing earnings, so its P/E is not meaningful; BeOne Medicines Ltd. - Sponsored ADR trades at 61.2×. Insmed, Inc. grew revenue faster over the last twelve months: 185.8% against 34.4%. BeOne Medicines Ltd. - Sponsored ADR has the higher net margin (10.7% vs −76.9%) and the higher return on invested capital (60.2% vs −329.2%). Across the 18 metrics below, BeOne Medicines Ltd. - Sponsored ADR leads on 16 and Insmed, Inc. on 2.

Valuation

Metric INSM ONC Biotechnology median
P/E n/m 61.16 7.88
P/S 22.51 6.57 11.47
P/B 33.81 7.78 2.52
Price to free cash flow n/m 30.73 21.16
EV/EBITDA n/m 34.08 0.74
EV/Sales 22.18 5.99 10.73
Earnings yield (3.49%) 1.64% (28.84%)
Free cash flow yield (3.15%) 3.25% (23.03%)

Profitability

Metric INSM ONC Biotechnology median
Gross margin 83.46% 88.89% 65.16%
Operating margin (73.89%) 15.06% 0.00%
Net margin (76.94%) 10.70% 0.00%
Free cash flow margin (71.00%) 21.70% 0.00%
Return on equity (87.22%) 14.66% (57.72%)
Return on assets (38.20%) 8.47% (49.22%)
Return on invested capital (329.22%) 60.22% 0.00%

Growth

Metric INSM ONC Biotechnology median
Revenue growth (TTM) 185.76% 34.35% 5.64%
EPS growth (last fiscal year) (15.26%) 141.34% —
Revenue growth, 5-year CAGR 29.83% 76.85% 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric INSM ONC Biotechnology median
Debt to equity 0.74 0.17 0.00
Current ratio 3.72 3.41 4.73
Net debt to EBITDA 0.71 (6.09) 0.96

Dividend

Metric INSM ONC Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric INSM ONC Biotechnology median
Market cap 26.84b 37.25b 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack